National Comprehensive Cancer Network



About NCCN

Acute Myeloid Leukemia Panel - Disclosures as of 2/28/2015

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Date Completed

Camille N. Abboud, MD

Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
Teva;
Pfizer Inc.

None

Teva

None

None

2/11/2015

Jessica Altman, MD

ARIAD Pharmaceuticals, Inc.;
Boehringer Ingelheim GmbH;
Bristol-Myers Squibb Company;
Millennium Pharmaceuticals, Inc.;
Agios;
Ambit;
Astellas;
Cyclacel;
Epizyme;
Lilly Pharmaceuticals;
Talon;
Pfizer Inc.

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Seattle Genetics;
Spectrum pharmaceuticals

None

None

None

2/17/2015

Frederick R. Appelbaum, MD

None

None

Amgen Inc.;
Celator;
National Marrow Donor Program;
Neumedicines, Inc

None

None

7/31/2014

Daniel A. Arber, MD

None

US Diagnostic Standards

None

None

None

5/2/2014

Marian Birkeland, PhD

None

None

None

None

None

10/7/2014

Dale Bixby, MD, PhD

Genentech, Inc.;
Johnson & Johnson;
Merck & Co., Inc.;
Ambit;
Celetor;
Igenica;
Novartis;
Onconova;
Pfizer Inc.

None

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation

None

None

8/6/2014

William Blum, MD

Boehringer Ingelheim GmbH;
Celgene Corporation;
Abbvie;
Agios;
Astellas;
Celator, Inc;
Celator, Inc;
Karyopharm;
Prism Pharma;
Stemline

None

None

None

None

12/19/2014

Uma Borate, MD

Eli Lilly and Company;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Seattle Genetics;
Pfizer Inc.

Alexion Pharmaceuticals, Inc.

Alexion Pharmaceuticals, Inc.

None

None

1/29/2015

Steven E. Coutre, MD

Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
AbbVie;
Gilead;
Pharmacyclics

Celgene Corporation

Celgene Corporation;
Novartis Pharmaceuticals Corporation;
AbbVie;
Gilead;
Pharmacyclics

None

None

9/16/2014

Amir T. Fathi, MD

None

Agios Pharmaceuticals;
Ariad Pharmaceuticals;
Seattle Genetics

None

None

None

1/20/2015

Fayna Ferkle, PharmD

None

None

None

None

None

10/14/2014

James M. Foran, MD

Bristol-Myers Squibb Company;
Bristol-Myers Squibb Company;
Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Celgene;
Incyte;
Seattle Genetics;
Seattle Genetics;
Tetralogic;
Tetralogic

ARIAD Pharmaceuticals, Inc.;
Boehringer Ingelheim GmbH;
Spectrum;
Pharmacyclics;
Sunesis Pharmaceuticals, Inc.

None

None

None

10/16/2014

Lauren Gallagher, RPh, PhD

None

None

None

None

None

12/8/2014

Steven D. Gore, MD

Celgene Corporation;
Johnson & Johnson;
Kyowa

Celgene Corporation

Celgene Corporation

None

None

5/20/2014

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

9/16/2014

Jeffrey Lancet, MD

Celgene Corporation;
Pfizer Inc.

;
Celgene Corporation

Boehringer Ingelheim GmbH;
Celgene Corporation;
Celator;
Seattle Genetics

None

None

7/31/2014

Lori J. Maness, MD

Cyclacel, LTD

None

None

None

None

1/7/2014

Guido Marcucci, MD

None

None

None

None

None

8/1/2014

Mary Ellen Martin, MD

None

None

None

None

None

8/13/2014

Michael G. Martin, MD

None

None

None

None

None

9/20/2014

Joan S. McClure, MS

None

None

None

None

None

12/8/2014

Joseph O. Moore, MD

ARIAD Pharmaceuticals, Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

ARIAD Pharmaceuticals, Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

ARIAD Pharmaceuticals, Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

None

None

2/15/2015

Margaret R. O'Donnell, MD

National Cancer Institute

None

None

None

None

8/6/2014

Rebecca Olin, MD

Amgen Inc.;
Daiichi- Sankyo Co.

None

None

None

None

5/27/2014

Daniel A. Pollyea, MD, MS

Celgene Corporation;
Abbvie;
Agios;
Pfizer Inc.

Celgene Corporation;
Agios

None

None

None

1/20/2015

Donna Powell, MS, CMD, RT(T)

None

None

None

None

None

10/1/2014

Farhad Ravandi, MD

Bayer HealthCare;
Celgene Corporation;
Celgene Corporation;
Merck & Co., Inc.;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
Sunesis Pharmaceuticals, Inc.;
Sunesis Pharmaceuticals, Inc.

Bayer HealthCare;
Cephalon, Inc.;
Eisai Inc.;
Genzyme Corporation;
Novartis Pharmaceuticals Corporation;
Sunesis Pharmaceuticals, Inc.

Amgen Inc.;
Sunesis Pharmaceuticals, Inc.

None

None

12/6/2013

Paul J. Shami, MD

Eisai Inc.;
Genzyme Corporation

ARIAD Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation

None

None

None

1/28/2013

B. Douglas Smith, MD

Bristol-Myers Squibb Company;
Merck & Co., Inc.;
CSL-Behring;
Pfizer Inc.

None

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation;
Incyte

None

None

2/11/2015

Courtney Smith, PhD

None

None

None

Johnson & Johnson;
OPKO

Ethos Health Communications

11/7/2014

Richard M. Stone, MD

Celgene Corporation;
Celgene Corporation;
Novartis Pharmaceuticals Corporation;
Sunesis Pharmaceuticals, Inc.

None

Amgen Inc.;
Celgene Corporation;
Abbvie;
Agios;
Celator;
Seattle Genetics;
Roche Laboratories, Inc.

None

None

7/7/2014

Stephen A. Strickland, MD, MSCI

Amgen Inc.;
Boehringer Ingelheim GmbH;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Ambit;
Astellas Pharma US;
Celator Pharmaceuticals;
Cyclacel Pharmaceuticals;
sanofi-aventis U.S.;
Sunesis Pharmaceuticals, Inc.

None

Amgen Inc.;
Spectrum Pharmaceuticals, Inc;
Sunesis Pharmaceuticals, Inc.

None

None

5/31/2014

Martin S. Tallman, MD

None

Boehringer Ingelheim GmbH;
Agios Pharmaceuticals;
Seattle Genetics

None

None

None

1/7/2014

Eunice S. Wang, MD

None

ARIAD Pharmaceuticals, Inc.

Incyte

None

None

6/10/2014

Matthew Wieduwilt, MD, PhD

Celgene Corporation;
Pfizer Inc.;
Sigma-Tau Pharmaceuticals, Inc.

None

None

None

None

9/20/2013